Pneumonia and urinary tract infection after acute ischaemic stroke: a tertiary analysis of the GAIN International trial
Top Cited Papers
- 24 December 2003
- journal article
- clinical trial
- Published by Wiley in European Journal of Neurology
- Vol. 11 (1) , 49-53
- https://doi.org/10.1046/j.1468-1331.2003.00749.x
Abstract
The third most common stroke complication is infection. We studied the rates of aspiration pneumonia and urinary tract infection (UTI), their risk factors and their effect on outcome in the 1455 Glycine Antagonist (Gavestinel) in Neuroprotection (GAIN) International patients with ischaemic stroke. Forward stepwise logistic regression and Cox proportional hazards modelling identified baseline factors that predicted events and the independent effect of events up to day 7 on poor stroke outcome at 3 months in patients alive at day 7, after correcting for prognostic factors. Higher baseline National Institute of Health Stroke Scale (NIHSS) and age, male gender, history of diabetes and stroke subtype predicted pneumonia, which occurred in 13.6% of patients. Female gender and higher baseline NIHSS and age predicted UTI, which occurred in 17.2% of patients. Pneumonia was associated with poor outcome by mortality (hazard ratio, 2.2; 95% confidence interval, 1.5–3.3), Barthel index (<60) (odds ratio, 3.8; 2.2–6.7), NIHSS (4.9; 1.7–14) and Rankin scale (≥2) (3.4; 1.4–8.3). UTI was associated with Barthel index (1.9; 1.2–2.9), NIHSS (2.2; 1.2–4.0) and Rankin scale (3.1; 1.6–4.9). Pneumonia and UTI are independently associated with stroke poor outcome. Patients with identified risk factors must be closely monitored for infection.Keywords
This publication has 13 references indexed in Scilit:
- Complications following Acute Ischemic StrokeEuropean Neurology, 2002
- Predicting functional outcome and survival after acute ischemic strokeZeitschrift für Neurologie, 2002
- Cerebral ischemia and inflammationCurrent Opinion in Neurology, 2001
- Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trialThe Lancet, 2000
- The Cyclooxygenase-2 Inhibitor NS-398 Ameliorates Ischemic Brain Injury in Wild-Type Mice but not in Mice with Deletion of the Inducible Nitric Oxide Synthase GeneJournal of Cerebral Blood Flow & Metabolism, 1999
- Anti-ICAM-1 Monoclonal Antibody R6.5 (Enlimomab) Promotes Activation of Neutrophils in Whole BloodThe Journal of Immunology, 1999
- Medical and Neurological Complications of Ischemic StrokeStroke, 1998
- MRI and Brainstem Auditory Evoked Potential Evidence of Eighth Cranial Nerve Involvement in Multiple SclerosisNeurology, 1997
- Complications After Acute StrokeStroke, 1996
- Classification and natural history of clinically identifiable subtypes of cerebral infarctionPublished by Elsevier ,1991